RESEARCH COLLABORATIONS CAN LEAD TO LIFE-CHANGING BREAKTHROUGHS
While the majority of our medicines are developed in house, we also participate in research and development collaborations with leading pharmaceutical companies and biotech firms to build new business models, develop collaborative partnerships and alliances, and expand our reach in the marketplace. And, we engage in academic research collaborations to maximize our scientific knowledge and contributions to patients.
LEARN ABOUT OTHER TYPES OF EISAI COLLABORATIONS
WE COLLABORATE GLOBALLY TO CREATE ALL KINDS OF INNOVATIONS
From medicine creation to manufacturing to marketing, Eisai collaborates with numerous partners across the globe. To learn more about these collaborations, please see our latest integrated report.
WE’RE COLLABORATING TO EXPAND ACCESS TO MEDICINES
As part of our hhc philosophy, Eisai is committeed to improving global access to medicines for the billions of people around the world who do not have essential healthcare and treatments. Understanding this international challenge, Eisai is collaborating with governments, international organizations, private entities and non-profit organizations.
There is still an unmet need for many patients with cancer. These patients and their families are in need of more treatment options, and this remains at the forefront of our collaborative efforts.
Takashi Owa, Ph.D. Chief Medicine Creation Officer and Chief Discovery Officer, Oncology Business Group
COME HELP US PURSUE THE NEXT BIG BREAKTHROUGH
We’re always looking for biotech, health tech and academic partners to help us innovate and address unmet medical needs. If that describes you, let’s talk.